STOCK TITAN

PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

PetMed Express (NASDAQ: PETS) has scheduled its fiscal third quarter 2025 earnings conference call for Monday, February 10, 2025, at 4:30 PM Eastern Time. The company will release its financial results for the quarter ended December 31, 2024, prior to the call.

The earnings call will include a management presentation followed by a Q&A session. Investors can access the call through U.S. dial-in (877-407-0789) or international number (201-689-8562). A replay will be available until February 24, 2025, accessible via toll-free (844-512-2921) or international (412-317-6671) numbers with passcode 13750886.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-5.18%
1 alert
-5.18% News Effect

On the day this news was published, PETS declined 5.18%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call.

PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time.

Date: Monday, February 10, 2025
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast: 3Q Earnings Webcast

A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through February 24, 2025.

Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13750886

About PetMed Express, Inc.

Founded in 1996, PetMeds is a leader in the consumer pet healthcare sector. As a national online retailer with expert pharmacists and licenses across fifty states, PetMeds.com and PetCareRx.com deliver top branded pharmaceuticals, generics, compounded prescription medications and OTC supplements and vitamins that help pets live longer, healthier lives. Leveraging telehealth and insurance partnerships, they offer unparalleled value and convenience that enhance wellness and longevity for dogs, cats, and horses. PetMeds and PetCareRx provides essential pet health offerings through their websites, www.PetMeds.com and www.PetCareRx.com.

Investor Contact:
ICR, LLC
John Mills
(646) 277-1254

Reed Anderson
(646) 277-1260

investor@petmeds.com


FAQ

When will PetMed Express (PETS) report Q3 2025 earnings?

PetMed Express will report its fiscal Q3 2025 earnings on Monday, February 10, 2025, with results released prior to the conference call scheduled for 4:30 PM Eastern Time.

How can investors access the PETS Q3 2025 earnings call?

Investors can access the call through the U.S. dial-in number (877-407-0789) or international number (201-689-8562). A webcast will also be available.

What period does PetMed Express (PETS) Q3 2025 earnings cover?

The earnings report covers the fiscal third quarter ended December 31, 2024.

How long will the PETS Q3 2025 earnings call replay be available?

The earnings call replay will be available until February 24, 2025, accessible via toll-free (844-512-2921) or international (412-317-6671) numbers with passcode 13750886.
Petmed Express Inc

NASDAQ:PETS

PETS Rankings

PETS Latest News

PETS Latest SEC Filings

PETS Stock Data

72.23M
14.68M
30.82%
37.94%
9.44%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States
DELRAY BEACH